UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation)
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code:
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| Item 4.02. | Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review. |
On November 20, 2023, OneMedNet Corporation (f/k/a Data Knights Acquisition Corp.) (the “Company”) determined that the Company’s unaudited consolidated financial statements and the notes thereto as of September 30, 2023 included in the Company’s Quarterly Report on Form 10-Q, filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 20, 2023 (the “Form 10-Q”) should no longer be relied upon.
The Form 10-Q was filed following the Company’s initial business combination and, subsequent to the filing thereof, it was determined that the Form 10-Q incorrectly included the unaudited consolidated financial statements and the notes thereto as of September 30, 2023 of OneMedNet Solutions Corporation, the target company in the Company’s initial business combination, instead of the Company’s unaudited consolidated financial statements and the notes thereto as of September 30, 2023, which financial statements and notes represent the financial statements and notes of the Company prior to its initial business combination. Accordingly, the Company and the Audit Committee of the Company’s Board of Directors determined that the unaudited consolidated financial statements and the notes thereto as of September 30, 2023 included in the Form 10-Q should not be relied upon. As a result, the Company will file an amendment to the Form 10-Q with the SEC to (i) remove the unaudited consolidated financial statements and the notes thereto as of September 30, 2023 of OneMedNet Solutions Corporation from the Form 10-Q and (ii) include the Company’s unaudited consolidated financial statements and the notes thereto as of September 30, 2023 in the Form 10-Q, which financial statements and notes represent the financial statements and notes of the Company prior to its initial business combination.
The Company’s management concluded that in light of the errors mentioned above, a material weakness existed in the Company’s internal control over financial reporting as of September 30, 2023, and the Company’s disclosure controls and procedures were not effective as of September 30, 2023.
The Company’s management and its Board of Directors have discussed the matters disclosed in this Current Report on Form 8-K pursuant to this Item 4.02 with Marcum LLP, the Company’s independent registered public accounting firm.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ONEMEDNET CORPORATION | ||
| Date: December 15, 2023 | By: | /s/ Paul J. Casey |
| Paul J. Casey | ||
| Chief Executive Officer | ||